Previous study demonstrated that metformin directly inhibits glioma cell proliferation through mechanisms such as the activation of the AMP-activated protein kinase(AMPK)/mammalian target of rapamycin(mTOR) signaling pathway, which disrupts cellular metabolism, induces autophagy, and promotes apoptosis in glioma cells (8). Here, MTOR is linked to central nervous system cancer.